Treatment of VEGF receptor inhibition, such as with nintedanib, is beneficial for patients with IPF [23], and adsorptive removal of circulating VEGF by polymyxin B haemoperfusion improves pulmonary oxygenation in AE-IPF [24]. Here, VEGFA is linked to idiopathic pulmonary fibrosis.